Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Olson Lisa, Director. Director active across 1 company, notably Magenta Therapeutics, Inc.. In total, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €66k. Activity tracked since 14 September 2021. The latest transaction was disclosed on 16 September 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Lisa Olson is a Board Member at Magenta Therapeutics, Inc. She plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. Her expertise and experience in the sector allow her to provide valuable insights to the board.